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Objective: The aim of this study was to evaluate the midterm clinical outcomes of various approaches, including hybrid
procedures, to aortic arch pathologies.
Methods: Of 305 consecutive patients who underwent aortic arch repair between 2005 and 2013, 244 underwent con-
ventional open total aortic arch repair (CTAR) with antegrade cerebral perfusion under circulatory arrest, 35 underwent
debranching of the arch with thoracic endovascular aortic repair (DTEVAR), and 26 underwent staged TEVAR after
TAR with elephant trunk (TARET). We retrospectively evaluated the outcomes of the three groups.
Results: The DTEVAR group had a greater percentage of patients with preoperative comorbidities. Signiﬁcant differences
were observed in 30-day mortality (DTEVAR, 14.3% [5 of 35] vs TARET TEVAR, 0% [0 of 26] vs CTAR, 5.3% [13 of
244]; P[ .045) and stroke (DTEVAR, 28.6% [10 of 35] vs TARET TEVAR, 7.7% [2 of 26] vs CTAR, 8.2% [20 of 244];
P[ .001). In overall midterm survival, the DTEVAR group had a lower survival rate (63.9% 3-year survival) compared
with the CTAR (90.1% 7-year survival) and the TARET TEVAR (95.5% 2.5-year survival) groups. In elective cases, better
midterm results were observed in CTAR and TARET TEVAR groups. An increased number of debranching graft and
emergency operations resulted in a much lower follow-up survival rate in the DTEVAR group. Atherosclerotic disease had
a great effect on midterm outcomes in the DTEVAR (P [ .045) and CTAR groups (P [ .002).
Conclusions: The clinical feasibility of DTEVAR for high-risk patients requiring zone 0 landing or emergency surgery is
still controversial. Atherosclerotic disease of the aorta has a signiﬁcant negative effect on midterm outcomes in any
surgical approach. (J Vasc Surg 2015;61:88-95.)Open surgical total aortic arch repair (TAR) is an estab-
lished procedure, with excellent results reported1-5 for
TAR with moderate hypothermia and antegrade cerebral
perfusion. The 5-year survival after TAR was reported to
be 70% to 80%.3-5 However, a dramatic evolution has
occurred in endovascular techniques coupled with changes
in surgical treatment strategies, including hybrid proce-
dures, with thoracic endovascular aortic repair (TEVAR)
being introduced to avoid the need for circulatory arrest
and hypothermia.6-10 As yet, reports of long-term follow-
up are limited, and controversy still exists regarding the
optimal approach to treat extensive aortic arch aneurysms
or aortic arch diseases requiring total debranching. In
hybrid arch repair with zone 0 proximal landing, for
example, early mortality ranged widely, from 0% to 30%.10
Especially in emergency cases or in patients with severe
comorbid status, selecting the appropriate procedure is
more difﬁcult. Therefore, we present a single institution’s
experience using a variety of surgical approaches to aortic
arch dissection and aneurysm, namely conventional totalthe Department of Cardiovascular Surgery, The Sakakibara Heart
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://dx.doi.org/10.1016/j.jvs.2014.06.121aortic arch repair (CTAR), debranching with TEVAR
(DTEVAR), and a combination of open TAR with elephant
trunk and TEVAR (TARET TEVAR), to evaluate the early-
term and midterm clinical outcomes among these groups.
METHODS
Between January 2005 and June 2013, 305 consecutive
patients underwent aortic arch repair (excluding hemiarch or
partial arch reconstruction) at a single cardiovascular institu-
tion. Of these, 91 emergency operations (29.8%) were per-
formed. The speciﬁc pathologies were aortic aneurysm in
196 patients (64.3%), aortic dissection in 67 (22.0%), and
both in 42 (13.8%). CTAR with moderate hypothermia and
antegrade cerebral perfusion, DTEVAR with one, two, and
three arch vessels debranching, andTARETTEVARwereper-
formed in244,35, and26patients, respectively.DTEVARwas
introduced in July 2010 and TARET TEVAR in December
2010. This study is a retrospective comparison of early and
midterm clinical outcomes among these different approaches
to aortic arch pathologies and was approved by the Institu-
tional Review Board. All patients or their relatives provided
written informed consent for inclusion into the cohort study.
We used the Ishimaru11 classiﬁcation to categorize the
proximal landing zone of TEVAR. In addition, a retrograde
approach was deﬁned as TEVAR delivered from the femoral
artery, and an antegrade approach was deﬁned as TEVAR
delivered from the ascending aorta through a prosthetic
graft. The effect of atherosclerotic changes in the ascending
and arch aorta on midterm survival was evaluated. Athero-
sclerotic plaque with a maximum size of $4 mm thick,
including the thickness of the aortic wall in the ascending
Fig 1. A, One debranching with thoracic endovascular aortic repair (TEVAR). B, Two debranching with TEVAR. C,
Total debranching with TEVAR.D, Staged TEVAR after open total aortic arch repair with elephant trunk (TARET).
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tor of vascular events12 and was deﬁned as signiﬁcant.
Surgical technique
Conventional TAR. TAR with antegrade cerebral
perfusion and moderate hypothermia (25C) has been pre-
viously reported and is brieﬂy described here.13 Femoral
artery and bicaval cannulations were routinely used to
establish cardiopulmonary bypass (CPB). Ascending aorta
and right axillary artery cannulation was appropriately
added. After systemic cooling to 25C for circulatory arrest,
cardiac arrest was achieved by antegrade and selective de-
liveries of cardioplegic solution into both coronary oriﬁces.
We checked nasopharyngeal and bladder temperature, and
mainly used bladder temperature as a core temperature for
systemic organ protection, including the spinal cord.
Antegrade cerebral perfusion (ACP) was established by
inserting 14F to 18F balloon catheters into the three cere-
bral branches. When cannulation of the right axillary artery
was used, the brachiocephalic artery was clamped for ACP.
The distal aortic arch was completely separated off at
the borderline between the lesion and normal aorta, and
the stepwise technique or a direct distal anastomosis was
used.14 Femoral artery perfusion was used to ﬂush out
debris after open distal anastomosis. After antegradesystemic perfusion through the branch of the graft was
restarted, the three cerebral vessels and proximal aorta
were reconstructed step-by-step.
Debranching with TEVAR. In 2010, we initially
introduced the debranching technique for high-risk pa-
tients with prior cardiac surgeries, severe pulmonary func-
tion failure (percentage forced vital capacity #80 and
percentage forced expiratory volume in 1 second of #70),
or more than moderately frail (help needed with all activ-
ities of daily living).15 Basically, the unilateral femoral or
iliac artery was exposed for the access site of TEVAR. A
one-debranching technique, comprising left carotid-left
axillary bypass with an 8-mm polytetraﬂuoroethylene
graft, was performed for zone 2 proximal landing, and a
two-debranching technique, comprising right axillary-left
common carotid and a left axillary bypass with an 8-mm
polytetraﬂuoroethylene T-shape graft, was performed for
zone 1 proximal landing. The ﬁrst portion of axillary artery
located between the clavicula and pectoralis minor muscle
was used for the anastomosis site, and coil embolization to
the left subclavian artery was routinely performed for the
prevention of persistent endoleaks after debranching
TEVAR (Fig 1, A and B). Type I hybrid arch repair, which
Bavaria et al16 previously reported, was used for patients
requiring total cervical rerouting (Fig 1, C). The ascending
Table I. Comparison of preoperative patient data
Variablesa DTEVAR (n ¼ 35) TARETþTEVAR (n ¼ 26) CTAR (n ¼ 244) P value
Age, years 73.0 6 9.6 73.7 6 9.6 71.4 6 11.1 .567
Female gender 6 (17) 9 (35) 74 (30) .225
Hypertension 27 (77) 21 (81) 202 (83) .709
Dyslipidemia 10 (29) 10 (38) 59 (24) .267
Diabetes mellitus 9 (26) 2 (8) 23 (9) .014
COPD 6 (17) 4 (15) 15 (6) .032
HD patient 4 (11) 0 (0) 8 (3) .038
Carotid stenosis 4 (11) 5 (19) 14 (6) .030
PVD 4 (11) 1 (4) 31 (13) .411
Previous sternotomy 6 (17) 1 (4) 3 (1) <.001
Emergency 9 (25.7) 1 (3.9) 81 (33.2) .007
Dissection 13 (37.1) 8 (30.8) 88 (36.1) .852
Ruptured aorta 8 (22.9) 1 (3.9) 22 (9.0) .022
LVEF, % 62.9 6 10.8 64.0 6 9.5 64.7 6 9.9 .579
COPD, Chronic obstructive pulmonary disease; CTAR, conventional total aortic arch repair; DTEVAR, debranching thoracic endovascular aortic repair; HD,
hemodialysis; LVEF, left ventricular ejection fraction; PVD, peripheral vascular disease; TARET, total aortic arch repair with elephant trunk; TEVAR, thoracic
endovascular aortic repair.
aContinuous variables are expressed as mean 6 standard deviation and categoric variables as number (%).
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underwent a combination of off-pump coronary artery
bypass grafting and TEVAR.17
TARET and TEVAR. This procedure was mainly
introduced for patients with extended aortic arch aneu-
rysm, as Kawaharada et al18 previously reported. Conven-
tional TARET through a median sternotomy using CPB,
hypothermic circulatory arrest, and ACP, was performed as
a ﬁrst-stage repair of the extended aneurysm. The elephant
trunk (5-7 cm in length) anastomosis was usually placed
between the left carotid and the left subclavian artery, and
the left subclavian artery was reconstructed directly. When
the location of the left subclavian artery was deep, trans-
location to the left axillary artery was performed, and the
left subclavian artery was ligated. In the event that a
retrograde approach of TEVAR from the femoral artery
was not feasible due to small tortuous calciﬁed iliac vessels,
the endograft was delivered through the side arm of the
branched graft after CPB was discontinued (antegrade
approach). The proximal landing was placed inside the
elephant trunk in ﬁve patients. In the remaining 20 pa-
tients, a second-stage TEVAR was performed in retrograde
fashion 10 to 14 days after the initial TAR. Fig 1, D depicts
three-dimensional computed tomography imaging after
TARET TEVAR.
Statistical analysis
Continuous data are presented as mean 6 standard de-
viation and were analyzed using two-tailed t-tests or
compared with a Mann-Whitney test for independent
data, as appropriate. Categoric variables are given as a
count and percentage of patients and were compared using
the c2 or Fisher exact test. A comparison among the three
groups was performed by the Kruskal-Wallis test for
continuous variables or the c2 test for categoric variables.
The survival rate between groups was compared by the
Kaplan-Meier model and the log-rank test. A P valueof < .05 was considered signiﬁcant. All data were analyzed
using the JMP 9.0 software (SAS Institute Inc, Cary, NC).
RESULTS
Patient demographics. The mean patient age was
71.8 6 10.8 years (range 35-92 years). Emergency surgery
was performed in 91 patients (29.8%). There were signiﬁ-
cant differences in preoperative comorbidities among the
three groups, with a greater percentage of diabetes melli-
tus, chronic obstructive pulmonary disease, renal failure,
and previous sternotomy in the DTEVAR group. A lower
percentage of emergency cases was seen in the TARET
TEVAR group. A comparison of preoperative characteris-
tics is provided in Table I.
Operative data. Operative time was signiﬁcantly
shorter in the DTEVAR group than in the other two
groups (both P < .001). There were no signiﬁcant differ-
ences in operative, CPB, cerebral perfusion, circulatory ar-
rest, and cardiac arrest times between the CTAR and
TARET TEVAR groups. In the DTEVAR group, ante-
grade access for TEVAR was used in 18 patients (51%),
and the number of patients with proximal landing zone
0, 1, and 2 was 7, 15, and 13, respectively. In the TARET
TEVAR group, one-stage TEVAR by antegrade access was
used in ﬁve patients (19%).
The Zenith TX2 endoprosthesis (Cook Inc, Blooming-
ton, Ind) was used in 21 patients and the Gore TAG endo-
prosthesis (WL Gore and Associates, Flagstaff, Ariz) was
used in 40 patients. Comparative operative data are re-
ported in Table II.
Postoperative data. The overall 30-day mortality was
5.9% (18 of 305), in-hospital mortality was 8.2% (25 of
305), and the overall occurrence of stroke was 10.5% (32 of
305). The postoperative data of each approach are reported
in Table III.
Debranching with TEVR. The 30-day and in-
hospital mortality in patients with elective surgery was
Table III. Postoperative data of different approaches
Variablesa DTEVAR (n ¼ 26) TARET þ TEVAR (n ¼ 25) CTAR (n ¼ 163) P value
Elective operation
30-day death 2 (7.7) 0 (0) 5 (3.1) .290
In-hospital death 5 (19.2) 0 (0) 8 (4.9) .007
Stroke 7 (26.9) 2 (8.0) 13 (8.0) .012
Fatal stroke 4 (15.4) 0 (0) 0 (0) <.001
Spinal cord injury 1 (3.9) 3 (12.0) 1 (0.6) .002
Postoperative hospital days 34.5 6 33.5 29.9 6 17.9 26.6 6 14.0 .294
(n ¼ 9) (n ¼ 1) (n ¼ 81)
Emergency operation
30-day death 3 (33.3) 0 (0) 8 (9.9) .115
In-hospital death 3 (33.3) 0 (0) 9 (11.1) .161
Stroke 3 (33.3) 0 (0) 7 (8.6) .075
Fatal stroke 2 (22.2) 0 (0) 3 (3.7) .067
SCI 0 (0) 0 (0) 5 (6.2) .721
Postoperative hospital
days
23.4 6 16.9 87.0 32.9 6 28.9 .147
CTAR, Conventional total aortic arch repair; DTEVAR, debranching thoracic endovascular aortic repair; OPCAB, off-pump coronary artery bypass grafting;
SCI, spinal cord injury; TARET, total aortic arch repair with elephant trunk; TEVAR, thoracic endovascular aortic repair.
aContinuous variables are expressed as mean 6 standard deviation and categoric variables as number (%).
Table II. Comparison of operative data
Variablesa DTEVAR (n ¼ 35) TARETþTEVAR (n ¼ 26) CTAR (n ¼ 244)
Operative time, min 285 6 85 443 6 89 446 6 110
CPB time, min 231 6 48 232 6 61
Cerebral perfusion time, min 124 6 33 135 6 31
Circulatory arrest time, min 60 6 13 63 6 20
Cardiac arrest time, min 138 6 41 143 6 37
Concomitant cardiac surgery
AVR 1 1 21
OPCAB 5
CABG 1 42
MVR 2
AVR þ CABG 8
Bentall procedure 1
Device access
Antegrade 17 6
Retrograde 18 20
Proximal landing
Zone 0 7
Zone 1 15
Zone 2 13
Stent graft device
TX2b 9 (26) 12 (46)
TAGc 26 (74%) 14 (54)
Stent graft length, cm 15.7 6 2.7 16.4 6 2.8
Distal extent 11 (31) 7 (27)
Length of extent graft 13.6 6 3.9 14.3 6 5.9
Residual type II endoleak 3 (8.6) 2 (7.7)
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; CTAR, conventional total aortic arch repair; DTE-
VAR, debranching thoracic endovascular aortic repair; MVR, mitral valve replacement; OPCAB, off-pump coronary artery bypass grafting; TARET, total
aortic arch repair with elephant trunk; TEVAR, thoracic endovascular aortic repair.
aContinuous variables are expressed as mean 6 standard deviation and categoric variables as number (%).
bZenith, Bloomington, Ind.
cW. L. Gore & Associates, Flagstaff, Ariz.
JOURNAL OF VASCULAR SURGERY
Volume 61, Number 1 Hiraoka et al 917.7% (2 of 26) and 19.2% (5 of 26), respectively. A
signiﬁcantly higher incidence of stroke and in-hospital
death was found compared with the other groups. Inemergency operations, there were no signiﬁcant differences
in postoperative data, but the 30-day and hospital mortality
rates were high (33.3%). Postoperative data categorized
Table IV. Postoperative data in debranching thoracic endovascular aortic repair (DTEVAR) group
Variablea
Proximal landing zone
P valueZone 0 (n ¼ 7) Zone 1 (n ¼ 15) Zone 2 (n ¼ 13)
30-day death 3 (42.9) 2 (13.3) 0 (0) .033
In-hospital death 5 (71.4) 2 (13.3) 1 (7.7) .003
Stroke 5 (71.4) 4 (26.7) 1 (7.7) .011
Fatal stroke 4 (57.1) 2 (13.3) 0 (0) .005
SCI 0 (0) 1 (6.7) 0 (0) .503
Postoperative hospital days 53.2 6 50.4 29.3 6 25.9 23.0 6 14.6 .513
SCI, Spinal cord injury.
aContinuous variables are expressed as mean 6 standard deviation and categoric variables as number (%).
Fig 2. A, Kaplan-Meier survival based on the respective approach to aortic arch diseases in all patients. There
was a signiﬁcant difference in midterm outcome among the three groups (P < .001). The 3-year survival rate
was 63.9% in the debranching with thoracic endovascular aortic repair (DTEVAR; dash-dot line) group, the
7-year survival rate was 90.1% in the conventional open total aortic arch repair (CTAR; solid line) group, and
the 2.5-year survival rate was 95.5% in the staged TEVAR after TAR with elephant trunk (TARETþTEVAR;
dashed line) group. B, Kaplan-Meier survival, based on the respective approach in elective cases (excluding
emergency cases), found there was a signiﬁcant difference in the midterm outcomes of elective operation
among the three groups (P ¼ .001).
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higher incidence of stroke (71.4%) and 30-day mortality
(42.9%) were observed in the group with zone 0 landing.
TARET with TEVAR. There were no 30-day or in-
hospital deaths in patients with elective surgery. However,
spinal cord injury (SCI) occurred more often in the TARET
TEVAR group (12.0% [2 of 25]; P ¼ .002). Multiple stent
grafts for extent were used in seven patients (27%), and
there was no signiﬁcant correlation in the total length of
stent graft between patients with and without spinal cord
ischemia (24.0 6 14.4 cm vs 19.7 6 8.0 cm; P ¼ .434).
Conventional TAR. The 30-day and in-hospital
mortality rates in patients with elective surgery were 3.1%
(5 of 163) and 4.9% (8 of 163), respectively. Stroke
occurred in 8.0% of elective operations. In emergency
cases, 30-day and in-hospital mortality was 9.9% (8 of 81)
and 11.1% (9 of 81), respectively.
There were no signiﬁcant differences in postoperative
data between patients with and without concomitant car-
diac surgeries in all approaches.Midterm outcome of respective approaches. There
was a signiﬁcant difference in the overall midterm out-
comes among the three groups (P < .001). The 3-year
survival rate was 63.9% in the DTEVAR group, the
7-year survival rate was 90.1% in the CTAR group, and
the 2.5-year survival rate was 95.5% in the TARET
TEVAR group (Fig 2, A). Similarly, midterm outcomes
of elective operations differed signiﬁcantly among the 3
groups (P ¼ .001; Fig 2, B). In the TARET TEVAR
group, one patient died of pneumonia 6 months after
surgery. In the DTEVAR group, the follow-up survival
rate was signiﬁcantly associated with proximal landing
zone classiﬁcation (P ¼ .008), and an increased number
of debranching grafts resulted in a lower follow-up
survival rate (Fig 3). An insigniﬁcant but lower follow-
up survival rate was documented in emergency cases
(1-year survival rate, 40.0%) compared with elective op-
erations (3-year survival rate, 72.1%) in the DTEVAR
groups (P ¼ .059; Fig 4, A). There was no signiﬁcant
difference in the midterm survival rate between patients
Fig 3. Kaplan-Meier survival based on proximal landing zone
in the debranching with thoracic endovascular aortic repair
(DTEVAR) group. An increased number of debranching grafts led
a lower follow-up survival rate (P ¼ .008).
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those with emergency operations in the CTAR group
(7-year survival, 87.6%; P ¼ .097; Fig 4, B).
The effect impact of atherosclerotic changes in the
ascending and arch aorta on midterm survival is shown in
Fig 5. Signiﬁcant atherosclerotic change was found in 16
patients (45.7%) in the DTEVAR group and in 76
(31.1%) in the CTAR group. A signiﬁcantly lower midterm
survival rate of patients with severe atherosclerotic change
was observed in the DTEVAR (P ¼ .045) and CTAR
groups (P ¼ .002).DISCUSSION
The indication of hybrid approaches for aortic arch pa-
thologies has been expanding, and several review studies
have been reported. Koullias et al19 reported a meta-
analysis of 15 studies with 463 patients who underwent
hybrid aortic arch repair (TAR with TEVAR, and DTE-
VAR). That study reported overall 30-day mortality of
8.3% and stroke rates of 4.4%.19 Cao et al20 reported a sys-
tematic review of 50 studies of 642 patients with arch
debranching, 1103 patients with frozen elephant trunk,
and 141 patients with a stented elephant trunk. Periopera-
tive mortality and stroke rate ranged widely, from 1.6% to
25.0% and from 0.8% to 25.0%, respectively.20 Because
open CTAR is an established procedure and there are
various hybrid approaches to aortic arch diseases and
different inclusion criteria, the objective beneﬁts of hybrid
repair and optimal strategy are still unknown compared
with CTAR. Several comparative studies between hybrid
repair and CTAR have been reported.21,22 Benedetto
et al23 reported a meta-analysis of four comparative obser-
vational studies, where superiority of the hybrid pro-
cedure could not be demonstrated. In the present study,early-term and midterm outcomes of DTEVAR were un-
satisfactory compared with CTAR, perhaps due to signiﬁ-
cant preoperative comorbidity and our developing
technique, which may have contributed to the high occur-
rence rate of perioperative cerebral infarction in the DTE-
VAR group (28.6%).
In emergency cases, there was no signiﬁcant difference
in the midterm results of CTAR, but perioperative and
early outcomes of emergency DTEVAR were signiﬁcantly
worse. In addition, the proximal landing (zone 0 or 1) of
TEVAR can be a risk for death and fatal stroke. A signiﬁ-
cantly greater percentage of fatal stroke was observed in pa-
tients with zone 0 landing (57.1% [4 of 7]) compared with
zone 1 (13.3% [2 of 15]) and zone 2 (0% [0 of 13]).
Considering these results, DTEVAR requiring total
debranching or emergency surgery is still an evolving op-
tion and not less invasive, especially for high-risk patients.
Protection from cerebral infarction during surgery is
crucial for DTEVAR to be a safer option, and shagginess
of the aorta is one of the most important risk factors. In
our experience, a higher incidence of cerebellar infarction
was observed; therefore, appropriate technique and timing
of reconstruction of the left subclavian artery were
thought to be important to prevent stroke. We intro-
duced a combination of temporary occlusion of the left
subclavian artery using balloon catheter before releasing
the stent graft and performance of coil embolization to
the proximal left subclavian artery after deployment of
the stent graft. After introduction of this technique,
occurrence of stroke has declined. However, arch vessels
were encircled and clamped on the beating heart in a total
debranching technique and may increase the risk of cere-
bral infarction.
In addition, atherosclerotic change in the aorta had a
signiﬁcantly greater effect on midterm mortality in the
DTEVAR and CTAR groups, emphasizing the difﬁculty
in determining the optimal surgical treatment strategy for
patients with triglyceride-rich atherosclerosis. The DTE-
VAR technique is an important option for patients with
high risk of open repair, and we have to continue to evolve
the technique.
On the basis of our results with DTEVAR and CTAR,
our institute selected TARET TEVAR as the primary
choice for patients with an extended aortic arch aneurysm.
Acceptable results were obtained in the TARET TEVAR
group; however, the high occurrence of SCI (11.5%) was
of paramount concern.
Although most SCIs were symptomatically transient,
extended coverage of thoracic aortic segments and simulta-
neous TEVAR can be a risk.24 However, the length of the
stent grafts was not signiﬁcantly correlated with SCI in this
study. We considered lower systemic mean blood pressure
after weaning from CPB in TAR can be a risk for SCI.
Therefore, a staged hybrid operation and preventive
methods of SCI, including lumbar spinal drainage, admin-
istration of naloxone, high blood pressure, and ample
oxygenation have become standard in the perioperative
management of TEVAR. We routinely used lumbar spinal
Fig 4. Kaplan-Meier survival based on emergency (dashed lines) vs elective (solid lines) operation in (A) debranching
with thoracic endovascular aortic repair (DTEVAR) group (P ¼ .059) and (B) in the conventional open total aortic
arch repair (CTAR) group (P ¼ .097).
Fig 5. Kaplan-Meier survival based on positive (solid line) and negative (dashed line) atherosclerotic (Athelo) change in
(A) the debranching with thoracic endovascular aortic repair (DTEVAR) group (P ¼ .045) and in (B) the conventional
open total aortic arch repair (CTAR) group (P ¼ .002).
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lesion covered with TEVAR by enhanced computed
tomography, but there was not enough time to detect it
in emergency operations, and the Adamkiewicz artery
was not detected in some cases. The appropriate interval
between the initial and second operation is still controver-
sial and will require further evaluation.
This study had several limitations. First, the study was a
retrospective analysis and did not have a matched compar-
ison group. Second, patients in the DTEVAR group had
signiﬁcantly different backgrounds and various comorbid-
ities. In addition, different ranges and pathologies of aortic
lesions can make it difﬁcult to evaluate the outcomes
evenly. Lastly, the sample size in the DTEVAR and
TARET TEVAR groups was relatively small.CONCLUSIONS
Appropriate approaches, including hybrid procedures with
TEVAR, were required for patients with various backgrounds
and risks. The results of our midterm clinical outcomes show
the clinical feasibility of DTEVAR remains controversial for
patients requiring zone 0 landing or emergency surgery
compared with CTAR and staged TARET TEVAR. Athero-
sclerotic disease of the aorta can have a signiﬁcant negative
effect on midterm clinical mortality after aortic arch repair.
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